Haisco Pharmaceutical Group Jiangsu Hengrui Medicine Co., Ltd
Wellstar physicians and patients can access eConsultsvirtual second opinionsat no additional cost to patients
Mild adverse events were similar between treatment and placebo groups, including headache, fatigue, and gastrointestinal symptoms
Indirect effects An indirect pathway for GLP-1RAs to mediate risk for PDAC is via acute or chronic pancreatitis, which are risk factors for PDAC 24,25
Whether youve achieved your weight loss goal or are transitioning off a GLP-1 medication, continuing monthly IV therapy and injections helps: Prevent post-diet sluggish metabolism Support muscle maintenance for long-term weight stability Balance energy levels for sustainable health At Nava Health, we recommend a personalized IV therapy plan based on your weight loss stage and metabolic needs
The GLP-1 wave keeps widening Semaglutide hits the GLP-1 receptor alone, tirzepatide adds a second in GIP, and next-generation candidates layer on a third in glucagon or drop incretins altogether for amylin and FGF21 biology
